At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BBH VanEck Biotech ETF
Market Closed 08-07 16:00:00 EDT
216.58
+5.91
+2.81%
盘后215.00
-1.58-0.73%
19:34 EDT
High216.58Low212.81Vol5.18K
Open213.36D1 Closing210.67Amplitude1.79%
Mkt Cap421.57MTradable Cap421.57MTotal Shares1.95M
T/O1.11MT/O Rate0.27%Tradable Shares1.95M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Amgen SVP, Chief Compliance Officer Nancy Grygiel Sells 2,970 Shares for $1.2 Million
Reuters  ·  06:46
Amgen SVP, Chief Compliance Officer Nancy Grygiel Sells 2,970 Shares for $1.2 Million
Gilead: Strong HIV and Oncology Growth Underpins Reiterated Buy Rating and Unchanged $165 Price Target
TIPRANKS  ·  06:05
Gilead: Strong HIV and Oncology Growth Underpins Reiterated Buy Rating and Unchanged $165 Price Target
Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day
Dow Jones  ·  04:36
Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day
Moderna Inc. Stock Climbs 9.9%, Outperforms Peers
Dow Jones  ·  04:33
Moderna Inc. Stock Climbs 9.9%, Outperforms Peers
Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock is Tumbling.
Dow Jones  ·  00:36
Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock is Tumbling.
Grail announces FDA advisory committee meeting to review Galleri test PMA
TIPRANKS  ·  08-07 23:10
Grail announces FDA advisory committee meeting to review Galleri test PMA
Sanofi, Regeneron Seem Keen to Keep Working Together
Dow Jones  ·  08-07 22:06
Sanofi, Regeneron Seem Keen to Keep Working Together
Alphabet Reports Share Stake in SpaceX, Fervo Energy and Parabilis Medicines
Reuters  ·  08-07 18:18
Alphabet Reports Share Stake in SpaceX, Fervo Energy and Parabilis Medicines
Alphabet Inc. Cuts Share Stake in Revolution Medicines Inc by 10.5% to 2.9 Mln Shares - SEC Filing
THOMSON REUTERS  ·  08-07 18:02
Alphabet Inc. Cuts Share Stake in Revolution Medicines Inc by 10.5% to 2.9 Mln Shares - SEC Filing
Sino Biopharmaceutical Stock Climbs 3.3% in Hong Kong, Outperforms Competitors
Dow Jones  ·  08-07 16:30
Sino Biopharmaceutical Stock Climbs 3.3% in Hong Kong, Outperforms Competitors
Moderna Inc. Stock Sheds 4.3%, Underperforms Peers
Dow Jones  ·  08-07 04:35
Moderna Inc. Stock Sheds 4.3%, Underperforms Peers
Regeneron Posts Transcript of Q2 2026 Earnings Conference Call
Reuters  ·  08-07 02:48
Regeneron Posts Transcript of Q2 2026 Earnings Conference Call
Vortex Energy Study Confirms Major Salt Structure and New Target at Robinsons River
TIPRANKS  ·  08-07 00:59
Vortex Energy Study Confirms Major Salt Structure and New Target at Robinsons River
Regeneron Canada Says Libtayo Receives Health Canada Approval for Treatment of a Type of Carcinoma
Reuters  ·  08-06 23:43
Regeneron Canada Says Libtayo Receives Health Canada Approval for Treatment of a Type of Carcinoma
Regeneron announces Health Canada approval of new indication for Libtayo
TIPRANKS  ·  08-06 23:35
Regeneron announces Health Canada approval of new indication for Libtayo
Regeneron Canada: Libtayo Receives Health Canada Approval for Adjuvant Treatment of High-Risk Cutaneous Squamous Cell Carcinoma
THOMSON REUTERS  ·  08-06 23:30
Regeneron Canada: Libtayo Receives Health Canada Approval for Adjuvant Treatment of High-Risk Cutaneous Squamous Cell Carcinoma
Bernstein Remains a Hold on Revolution Medicines (RVMD)
TIPRANKS  ·  08-06 23:01
Bernstein Remains a Hold on Revolution Medicines (RVMD)
Salesforce, UnitedHealth Share Losses Contribute to Dow's Nearly 150-Point Drop
Dow Jones  ·  08-06 22:46
Salesforce, UnitedHealth Share Losses Contribute to Dow's Nearly 150-Point Drop
Analysts Have Conflicting Sentiments on These Healthcare Companies: Revolution Medicines (RVMD), Royalty Pharma (RPRX) and Urogen Pharma (URGN)
TIPRANKS  ·  08-06 20:10
Analysts Have Conflicting Sentiments on These Healthcare Companies: Revolution Medicines (RVMD), Royalty Pharma (RPRX) and Urogen Pharma (URGN)
Intellia Therapeutics Q2 Collaboration Revenue Falls, Net Loss Widens
Reuters  ·  08-06 19:20
Intellia Therapeutics Q2 Collaboration Revenue Falls, Net Loss Widens
No data available

Introduction

Company Name.
VanEck Biotech ETF
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Issue price:
--